CD8A and granular corneal dystrophy type II: Interestingly, Gimenez-Rivera demonstrated that MCs limit the exacerbation of chronic ACD by controlling TH1 and TH17 cytokines, and CD8+ tissue-resident memory T (TRM) cells, probably by degradation of the CD8+ T cell mitogen IL-15 [297].